Animal Vaccine Market Segments, Industry Growth, Size, Share, Key Players and Report 2023-2028

The latest report published by IMARC Group, titled "Animal Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028", offers a comprehensive analysis of the industry, which comprises insights on animal vaccine market. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global animal vaccine market size reached US$ 12.38 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.88 Billion by 2028, exhibiting a growth rate (CAGR) of 8.04% during 2023-2028.

Animal vaccines are biologically prepared substances designed to stimulate an immune response in animals, providing them with protection against various infectious diseases. They help prevent the spread of diseases and reduce their impact on animal populations, livestock, and pets. These vaccines contain weakened or inactivated pathogens, antigens, or components of the disease-causing agents, which trigger the animal's immune system to produce antibodies without causing the disease itself. They play a crucial role in veterinary medicine and animal husbandry, safeguarding both individual animals and the larger animal populations. They are extensively used in livestock farming, poultry production, aquaculture, and pet care. Regular vaccination schedules are essential to maintain herd or flock immunity, prevent disease outbreaks, and ensure the overall health and well-being of animals.

Request to Get the Sample Report: https://www.imarcgroup.com/animal-vaccine-market/requestsample

Market Trends:

The global animal vaccine market is primarily driven by the increasing incidence of infectious diseases among animals, such as livestock and pets. Moreover, the rising demand for animal-derived products, including meat, milk, and eggs, has fueled the need for effective vaccination programs to ensure the health and productivity of livestock. Consumers are becoming conscious of food safety and quality, which augments the adoption of preventive measures, such as vaccinations in animal husbandry. Furthermore, stringent government regulations and initiatives aimed at controlling and eradicating infectious diseases in animals have contributed to the growth of the animal vaccine market. Moreover, advancements in biotechnology and the development of innovative vaccine technologies have played a vital role in expanding the market. Also, the growing awareness among pet owners about the importance of preventive healthcare for their companion animals is creating a positive market outlook.

Explore Full Report with Table of Contents: https://www.imarcgroup.com/animal-vaccine-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• C.H. Boehringer Sohn AG & Co. KG
• Ceva Sante Animale
• Elanco Animal Health Incorporated (Eli Lilly and Company)
• Hester Biosciences Limited
• Hipra S.A.
• Hygieia Biological Laboratories
• Merck & Co. Inc.
• Phibro Animal Health Corporation
• Vaxxinova GmbH (EW Group)
• Virbae
• Zoetis Services LLC

Animal Vaccine Market Segmentation:

Our report has categorized the market based on region, product, animal type, route of administration.

Breakup by Product:
• Attenuated vaccines
• Inactivated vaccines
• Subunit vaccines
• Toxoid vaccines
• Conjugate vaccines
• Recombinant vaccines
• DNA vaccines Type

Breakup by Animal Type:
• Companion animal
o Dogs
o Cats
• Livestock animal
o Cattle
o Pigs
o Poultry
o Sheep
o Others
• Aquaculture

Breakup by Route of Administration:
• Subcutaneous
• Intramuscular
• Intranasal
• Others

Breakup by Region:
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:
• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.